Fractional Radiofrequency (FRF) is a skin-treatment technology that delivers radiofrequency energy through an array of electrodes to create a pixelated pattern of controlled thermal injury in the epidermis and dermis. The fractional pattern leaves untreated skin between treatment zones, which speeds healing while triggering collagen remodeling in treated tissue.
What is Fractional Radiofrequency (FRF)?
FRF splits RF output across many small electrodes or microneedle pins instead of one continuous electrode surface. Each pin or contact point produces its own microthermal zone, separated by untreated skin. That fractional delivery pattern is what separates FRF from bulk monopolar or bipolar RF systems, which heat a continuous area rather than a grid of discrete points.
Two architectures dominate the category. Non-invasive FRF applies energy through a pin or electrode array that contacts the skin surface without breaking it. Invasive FRF, often called fractional microneedle radiofrequency (FMR), uses insulated microneedles to carry RF energy past the epidermis and release it at a set dermal depth, sparing the surface layer. In device terms, FRF platforms belong to the energy-based aesthetic device category, built as electromechanical systems with an RF generator, a control interface, and a handpiece or applicator that is often a single-use or limited-use accessory.
Why Fractional Radiofrequency (FRF) matters in medical device development
FRF sits at the intersection of electrical energy delivery and direct patient contact, so the margin for error is narrow. A generator that miscalibrates power output, or a microneedle array with inconsistent penetration depth, can produce burns, scarring, or uneven results instead of the intended cosmetic outcome.
Regulatory consequences follow closely behind clinical ones. FDA reviewers and EU notified bodies treat predictable, repeatable energy delivery as a core safety requirement, not a performance nicety. A design that cannot demonstrate consistent depth and power control across manufacturing lots invites additional testing requests, delayed clearance, and post-market complaints.
Time-to-market is also at stake. FRF devices typically clear as Class II devices, so early design and verification decisions around energy delivery accuracy and applicator reliability determine whether a submission proceeds smoothly or triggers additional information requests.
How Fractional Radiofrequency (FRF) works
An FRF system generates RF current and routes it through an applicator containing an array of electrodes or microneedle pins. Each pin acts as an independent energy channel, producing many small, evenly spaced thermal zones in a single pass instead of one large heated area.
Core components include:
- RF generator and control electronics, setting frequency, power, and pulse duration within tight tolerances across the device’s service life.
- Electrode or microneedle array, where pin count, spacing, insulation length for invasive designs, and depth shape the thermal pattern.
- Impedance sensing and feedback, since tissue impedance varies between patients and sites, and the generator needs real-time feedback to avoid under- or overtreatment.
- Patient-contact materials, which must meet biocompatibility requirements given repeated skin contact.
Manufacturers typically test FRF systems to IEC 60601-1 for general electrical safety and essential performance, and IEC 60601-2-2 for particular requirements covering high-frequency equipment. Risk management follows ISO 14971, usability engineering aligns with IEC 62366-1, and FDA review commonly falls under 21 CFR Part 878 for general and plastic surgery devices. In the EU, FRF systems are regulated under EU MDR 2017/745, with classification driven by invasiveness and duration of tissue contact.
Common challenges and best practices
Teams new to FRF design often underestimate how much the electrode array drives clinical outcome. A generator can be calibrated perfectly on the bench and still produce inconsistent results if pin spacing, insulation tolerances, or needle sharpness vary between production lots. Good practice treats the applicator as a critical-to-quality component with its own incoming inspection and process validation, not as a passive accessory to the generator.
A second common gap is under-testing across skin types. Impedance and thermal response differ between patients, and a design verified only on a narrow bench model can behave unpredictably in clinical use. Building impedance variability into verification testing, rather than treating it as a clinical-stage discovery, catches issues earlier and more cheaply.
Human factors work gets compressed too often as well. Depth and power settings that are easy to misdial under time pressure are a known source of adverse events across energy-based aesthetic devices, so usability testing under realistic conditions matters as much as electrical bench data.
How SJML helps with Fractional Radiofrequency (FRF)
SJML’s design and engineering group works across radiofrequency-based platforms as part of its broader energy-based and aesthetic device experience, covering concept through design transfer for electromechanical systems that combine generators, control electronics, and patient-contact applicators. Design work includes circuit and embedded software development, risk management aligned to ISO 14971, and usability engineering under IEC 62366-1, backed by in-house electrical safety and IEC 60601 testing labs. On the regulatory side, SJML’s QARA team supports classification strategy, technical file preparation, and clinical evaluation for FRF and related RF aesthetic device programs across FDA and EU MDR pathways.
Talk to SJML’s engineering team →
Frequently asked questions
No. Both create a grid of small treatment zones, but the energy source differs. FRF uses electrical current passed through electrodes or microneedles to generate heat in tissue, while fractional lasers use light energy absorbed by chromophores such as melanin and hemoglobin. Because FRF heating depends on electrical impedance rather than light absorption, its interaction with skin does not vary with melanin content the way laser-tissue interaction does.
Non-invasive FRF delivers RF energy through electrodes that contact the skin surface without breaking it, treating the epidermis and upper dermis. Invasive FRF, or fractional microneedle radiofrequency, uses insulated microneedles to bypass the epidermis and deliver energy directly at a set depth in the dermis, allowing a stronger effect with less surface disruption.
FRF devices are typically evaluated against IEC 60601-1 for general electrical safety and essential performance, with IEC 60601-2-2 covering particular requirements for high-frequency equipment. ISO 14971 governs risk management, and IEC 62366-1 governs usability engineering. In the US, FDA review commonly falls under 21 CFR Part 878; in the EU, FRF devices are regulated under EU MDR 2017/745.
Most FRF systems are cleared as Class II devices in the US, subject to special controls, and typically fall into Class IIa or IIb under EU MDR depending on the duration and depth of tissue contact. Invasive microneedle-based FRF systems generally face closer scrutiny than non-invasive designs because of the added risk from skin penetration.
Related terms
- Fractional Laser Resurfacing
- Energy-Based Aesthetic Device
- IEC 60601-2-2
- Fractional Microneedle Radiofrequency (FMR)
- Design Verification
